Correction

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014)

Journal

ANNALS OF ONCOLOGY
Volume 28, Issue 11, Pages 2899-2899

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdw349

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available